The current PE ratio of AZTA cannot be calculated, as the latest EPS of -$3.09 is negative. The last PE ratio of Azenta, recorded in December 2022, was 2.1.
The PE ratio of Azenta has averaged 34.52 over the last ten years. Looking back at the last ten years, AZTA's PE ratio peaked in the Jun 2015 quarter at 104.09, when the price was $11.45 and the EPS was $0.11. The lowest point was in the Sep 2022 quarter, when it reached 1.5 with a price of $42.86 and an EPS of $28.48.
Maximum annual increase: 763.22% in 2020
Maximum annual decrease: -97.82% in 2022
Year | PE ratio | Change |
---|---|---|
2024 | N/A | N/A |
2023 | N/A | N/A |
2022 | 1.5 | -97.82% |
2021 | 68.69 | 30.66% |
2020 | 52.57 | 763.22% |
2019 | 6.09 | -71.31% |
2018 | 21.23 | -37.06% |
2017 | 33.73 | N/A |
2016 | N/A | N/A |
2015 | 55.76 | 149.37% |
Stock name | PE ratio | Market cap |
---|---|---|
OMIC Singular Genomics Systems Inc | N/A | $49.11M |
NWBO Northwest Biotherapeutics Inc | N/A | $337.34M |
AZTA Azenta Inc | N/A | $2.77B |
The current price to earnings ratio of AZTA cannot be determined, as its EPS of -$3.09 is negative.
The average PE ratio for AZTA stock over the past 3 years is 13.76.
The average PE ratio for AZTA stock over the past 5 years is 30.69.
Over the last ten years, the quarterly PE ratio reached its highest level at 104.09 in the Jun 2015 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.